News Sentiment

NKTX sentiment intelligence

Nkarta Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed

Weighted score 53 Balanced news tone 31 relevant articles

Exchange NASDAQ United States

Sector Healthcare Market context

Industry Biotechnology Read-through group

Latest close 2.97 Week of 10 Jul 2026

Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 23

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

-7.8% over one week, +3.8% over four weeks, trend active, and near fair-value range.

Latest direct headline Positive

Companies Like Nkarta (NASDAQ:NKTX) Are In A Position To Invest In Growth

Market Reaction

Price moving ahead of tone

62/100 confidence

Primary event Market update 81/100 classification

One-week reaction -7.8% Price reacting lower

Trend fit Trend active 3.8% over four weeks

Fair value -18.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance

Positive 7

Neutral 22

Negative 2

Relevance

Why the article matched

Direct first

Direct company coverage 23

Industry context 8

Sector context 0

Sources

Coverage mix

Publishers

Market source 8

Stock Titan 6

simplywall.st 5

GlobeNewswire 2

Investing.com 2

Zacks Investment Research 2

MarketBeat 2

MT Newswires 1

Event Lens

What the news is about

Classified themes

Market update 17

Earnings 11

Analyst action 1

Balance sheet 1

Guidance 1

Sentiment Trail

Score over time

50 baseline

Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 31

Market source Industry context

Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks

Tone: Neutral 50/100
Event: Earnings
Published: 13 Jul 2026 12:30
Source: Market source

simplywall.st Direct company coverage

Companies Like Nkarta (NASDAQ:NKTX) Are In A Position To Invest In Growth

Tone: Positive 66/100
Event: Market update
Published: 07 Jul 2026 10:19
Source: simplywall.st

GlobeNewswire Direct company coverage

Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Tone: Neutral 50/100
Event: Market update
Published: 26 Jun 2026 12:45
Source: GlobeNewswire

Stock Titan Direct company coverage

Nkarta sets June 30 fireside chat on CAR-NK autoimmune therapy

Tone: Neutral 50/100
Event: Market update
Published: 26 Jun 2026 07:00
Source: Stock Titan

MT Newswires Direct company coverage

TD Cowen Initiates Nkarta at Buy

Tone: Positive 58/100
Event: Market update
Published: 23 Jun 2026 10:05
Source: MT Newswires

Investing.com Direct company coverage

TD Cowen initiates Nkarta stock with buy rating on NK cell therapy

Tone: Positive 66/100
Event: Analyst action
Published: 23 Jun 2026 07:00
Source: Investing.com

Stock Titan Direct company coverage

Nkarta (NASDAQ: NKTX) reports 37,000-share option grant tied to RA Capital

Tone: Neutral 50/100
Event: Market update
Published: 11 Jun 2026 07:00
Source: Stock Titan

Stock Titan Direct company coverage

Nkarta (NKTX) director granted 37,000 stock options for RA Capital funds

Tone: Neutral 50/100
Event: Market update
Published: 11 Jun 2026 07:00
Source: Stock Titan

Stock Titan Direct company coverage

Nkarta director granted options on 37,000 shares | NKTX Insider Trading

Tone: Neutral 50/100
Event: Market update
Published: 11 Jun 2026 07:00
Source: Stock Titan

Stock Titan Direct company coverage

Nkarta (NKTX) director awarded 37,000 stock options vesting in 2027

Tone: Neutral 50/100
Event: Market update
Published: 11 Jun 2026 07:00
Source: Stock Titan

simplywall.st Direct company coverage

Nkarta Insider Stock Sellers Must Be Relieved As Market Cap Falls To US$201m

Tone: Negative 34/100
Event: Market update
Published: 15 May 2026 07:00
Source: simplywall.st

simplywall.st Industry context

There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings

Tone: Negative 34/100
Event: Earnings
Published: 15 May 2026 07:00
Source: simplywall.st

Market source Direct company coverage

Here's Why We're Not Too Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Situation

Tone: Neutral 50/100
Event: Balance sheet
Published: 14 May 2026 07:00
Source: Market source

Market source Industry context

Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings

Tone: Neutral 50/100
Event: Earnings
Published: 14 May 2026 07:00
Source: Market source

GlobeNewswire Direct company coverage

Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights

Tone: Neutral 50/100
Event: Earnings
Published: 12 May 2026 20:01
Source: GlobeNewswire

simplywall.st Industry context

Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results

Tone: Positive 66/100
Event: Earnings
Published: 11 May 2026 07:00
Source: simplywall.st

Market source Industry context

Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00

Tone: Neutral 50/100
Event: Earnings
Published: 11 May 2026 07:00
Source: Market source

Market source Industry context

Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks

Tone: Neutral 50/100
Event: Earnings
Published: 25 Apr 2026 07:00
Source: Market source

Market source Industry context

Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)

Tone: Neutral 50/100
Event: Earnings
Published: 21 Apr 2026 07:00
Source: Market source

Zacks Investment Research Direct company coverage

Should I buy Nkarta (NKTX)

Tone: Positive 66/100
Event: Market update
Published: 17 Apr 2026 07:00
Source: Zacks Investment Research

Zacks Investment Research Direct company coverage

What date does Nkarta's (NKTX) report Earnings - Earnings Calendar & Announcement

Tone: Neutral 50/100
Event: Earnings
Published: 17 Apr 2026 07:00
Source: Zacks Investment Research

Seeking Alpha Direct company coverage

Nkarta wins FDA nod for new trial protocol (NKTX:NASDAQ)

Tone: Neutral 50/100
Event: Market update
Published: 16 Apr 2026 07:00
Source: Seeking Alpha

TradingView Industry context

A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack

Tone: Neutral 50/100
Event: Earnings
Published: 29 Mar 2026 07:00
Source: TradingView

Market source Direct company coverage

Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights

Tone: Neutral 50/100
Event: Earnings
Published: 25 Mar 2026 07:00
Source: Market source

Investing.com Direct company coverage

Nkarta CEO Hastings sells $53,915 in NKTX stock

Tone: Neutral 50/100
Event: Market update
Published: 20 Jan 2026 08:00
Source: Investing.com

Market source Direct company coverage

We Think Nkarta (NASDAQ:NKTX) Needs To Drive Business Growth Carefully

Tone: Positive 66/100
Event: Market update
Published: 04 Dec 2025 08:00
Source: Market source

simplywall.st Direct company coverage

Is Nkarta (NASDAQ:NKTX) In A Good Position To Deliver On Growth Plans?

Tone: Positive 66/100
Event: Market update
Published: 01 Nov 2025 07:00
Source: simplywall.st

Stock Titan Direct company coverage

Nkarta (NASDAQ: NKTX) presenting ACR 2025 poster on NKX019, including B-cell depletion data

Tone: Neutral 50/100
Event: Market update
Published: 22 Oct 2025 07:00
Source: Stock Titan

Quiver Quantitative Direct company coverage

Nkarta, Inc. to Present Clinical Data for NKX019 Therapy at ACR Convergence 2025 Meeting

Tone: Neutral 50/100
Event: Market update
Published: 22 Oct 2025 07:00
Source: Quiver Quantitative

MarketBeat Direct company coverage

Nkarta (NKTX) Stock Forecast and Price Target 2026

Tone: Neutral 50/100
Event: Guidance
Published: 11 May 2024 14:44
Source: MarketBeat